Mitchell Davis
Impact in
- Hepatology top 0.2%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 26
- Hepatitis C virus research 25
- Epidemiology 15
- Hepatitis B Virus Studies 8
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- Eric Lawitz (9 shared papers)Eugene R. Schiff (4 shared papers)Jonathan McCone (7 shared papers)Joseph Galati (7 shared papers)Kenneth Koury (3 shared papers)Lisa D. Pedicone (5 shared papers)Clifford A. Brass (6 shared papers)Janice K. Albrecht (5 shared papers)
- Journals
- Journal of Hepatology (12 papers)Hepatology (5 papers)Gastroenterology (3 papers)The Lancet (3 papers)Annals of Internal Medicine (2 papers)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Mitchell Davis
36 papers receiving 2.3k citations
Mitchell Davis's Hit Papers
Peers
Comparison fields: 5 of 77
- Hepatology 2.2k
- Epidemiology 1.3k
- Infectious Diseases 278
- Rheumatology 159
- Virology 24
Countries citing papers authored by Mitchell Davis
This map shows the geographic impact of Mitchell Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Davis more than expected).
Fields of papers citing papers by Mitchell Davis
This network shows the impact of papers produced by Mitchell Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Davis. The network helps show where Mitchell Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection Hit paper breakdown → | 2009 | 915 |
| 2 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial Hit paper breakdown → | 2010 | 532 |
| 3 | 2013 | 234 | |
| 4 | 2016 | 149 | |
| 5 | 2015 | 88 | |
| 6 | 2009 | 68 | |
| 7 | 2017 | 61 | |
| 8 | 2015 | 53 | |
| 9 | 2008 | 32 | |
| 10 | 2012 | 31 | |
| 11 | 2016 | 24 | |
| 12 | 2014 | 24 | |
| 13 | 2012 | 22 | |
| 14 | 2010 | 21 | |
| 15 | 2013 | 17 | |
| 16 | 2003 | 16 | |
| 17 | 2024 | 8 | |
| 18 | 1973 | 8 | |
| 19 | 2011 | 7 | |
| 20 | 2019 | 6 |
About Mitchell Davis
Mitchell Davis is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Genetics and Genetics, having authored 39 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (7 papers), HIV/AIDS drug development and treatment (3 papers), Platelet Disorders and Treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Wound Healing and Treatments (2 papers) and Blood groups and transfusion (2 papers). The work is most often cited by research in Hepatology (2.2k citations), Epidemiology (1.3k citations), Infectious Diseases (278 citations), Rheumatology (159 citations) and Virology (24 citations). Mitchell Davis has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Eric Lawitz, Eugene R. Schiff, Jonathan McCone, Joseph Galati, Kenneth Koury, Lisa D. Pedicone, Clifford A. Brass, Janice K. Albrecht, John G. McHutchison and Mark Sulkowski. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, The Lancet and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.